0000858744-18-000018.txt : 20180214
0000858744-18-000018.hdr.sgml : 20180214
20180213194547
ACCESSION NUMBER: 0000858744-18-000018
CONFORMED SUBMISSION TYPE: SC 13G/A
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20180214
DATE AS OF CHANGE: 20180213
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: GW PHARMACEUTICALS PLC
CENTRAL INDEX KEY: 0001351288
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FILING VALUES:
FORM TYPE: SC 13G/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-87941
FILM NUMBER: 18606302
BUSINESS ADDRESS:
STREET 1: SOVEREIGN HOUSE
STREET 2: VISION PARK
CITY: HISTON, CAMBRIDGE CB24 9BZ
STATE: X0
ZIP: 00000
BUSINESS PHONE: 44 1223 266800
MAIL ADDRESS:
STREET 1: SOVEREIGN HOUSE
STREET 2: VISION PARK
CITY: HISTON, CAMBRIDGE CB24 9BZ
STATE: X0
ZIP: 00000
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: SMALLCAP WORLD FUND INC
CENTRAL INDEX KEY: 0000858744
STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000]
IRS NUMBER: 954253845
FISCAL YEAR END: 0930
FILING VALUES:
FORM TYPE: SC 13G/A
BUSINESS ADDRESS:
STREET 1: 6455 IRVINE CENTER DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 213-486-9501
MAIL ADDRESS:
STREET 1: 333 S HOPE ST - 55TH FLOOR (GYR)
CITY: LOS ANGELES
STATE: CA
ZIP: 90071
FORMER COMPANY:
FORMER CONFORMED NAME: SMALLCAP FUND INC
DATE OF NAME CHANGE: 19900205
SC 13G/A
1
edggwph.txt
SC 13G/A
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 3)*
GW Pharmaceuticals plc
(Name of Issuer)
Ordinary Shares
(Title of Class of Securities)
36197T103
(CUSIP Number)
December 29, 2017
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[X] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information
which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).
CUSIP: 36197T103 Page 1 of 5
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
SMALLCAP World Fund, Inc.
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE
INSTRUCTIONS) (a)
(b)
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Maryland
5 SOLE VOTING POWER
NONE
6 SHARED VOTING POWER
NUMBER OF
SHARES NONE
BENEFICIALL
Y OWNED BY
7 SOLE DISPOSITIVE POWER
EACH
REPORTING NONE
PERSON
WITH:
8 SHARED DISPOSITIVE POWER
NONE
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
26,247,505 See Additional information in Item 4.
Under certain circumstances, SMALLCAP World Fund, Inc. may vote the
shares of the fund. These shares may also be reflected in a filing
made by Capital Research Global Investors, Capital International
Investors, and/or Capital World Investors.
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS)
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.8%
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IV
CUSIP: 36197T103 Page 2 of 5
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Schedule 13G
Under the Securities Exchange Act of 1934
Amendment No. 3
Item 1(a) Name of Issuer:
GW Pharmaceuticals plc
Item 1(b) Address of Issuer's Principal Executive Offices:
Sovereign House, Vision Park
Histon, Cambridge CB24 9BZ
United Kingdom
Item 2(a) Name of Person(s) Filing:
SMALLCAP World Fund, Inc.
Item 2(b) Address of Principal Business Office or, if none,
Residence:
6455 Irvine Center Drive
Irvine, California 92618-4518
Item 2(c) Citizenship: N/A
Item 2(d) Title of Class of Securities:
Ordinary Shares
Item 2(e) CUSIP Number:
36197T103
Item 3 If this statement is filed pursuant to sections 240.13d-1(b)
or 240.13d-2(b) or (c), check whether the person filing is a:
(d) [X] Investment company registered under section 8
of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
Item 4 Ownership
Provide the following information regarding the aggregate
number and percentage of the class of securities of the issuer
identified in Item 1.
(a) Amount beneficially owned:
(b) Percent of class:
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
(ii) Shared power to vote or to direct the vote:
(iii) Sole power to dispose or to direct the disposition of:
(iv) Shared power to dispose or to direct the disposition of:
See page 2
SMALLCAP World Fund, Inc., an investment company registered
under the Investment Company Act of 1940, which is advised by
Capital Research and Management Company ("CRMC"), is the
beneficial owner of 26,247,505 shares or 7.8% of the
337,559,736 shares believed to be outstanding. CRMC manages
equity assets for various investment companies through three
CUSIP: 36197T103 Page 3 of 5
divisions, Capital Research Global Investors, Capital World
Investors, and Capital International Investors. These divisions
generally function separately from each other with respect to
investment research activities and they make investment
decisions and proxy voting decisions for the investment
companies on a separate basis.
All of the shares reported are held in the form of American
Depositary Shares, which each represent 12 Ordinary Shares.
Item 5 Ownership of Five Percent or Less of a Class. If this
statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities,
check the following: [ ]
Item 6 Ownership of More than Five Percent on Behalf of Another
Person: N/A
Item 7 Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent Holding
Company or Control Person: N/A
Item 8 Identification and Classification of Members of the Group:
N/A
Item 9 Notice of Dissolution of Group: N/A
Item 10 Certification
By signing below, I certify that, to the best of my knowledge
and belief, the securities referred to above were acquired and
are held in the ordinary course of business and were not
acquired and are not held for the purpose of or with the effect
of changing or influencing the control of the issuer of the
securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose
or effect.
Signature
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this
statement is true, complete and correct.
Date: February 6, 2018
Signature: /s/ Michael W. Stockton
Name/Title: Michael W. Stockton - Secretary
SMALLCAP World Fund, Inc.
CUSIP: 36197T103 Page 4 of 5
CUSIP: 36197T103 Page 5 of 5